HRP930239A2
(en )
1996-06-30
Anti-inflamatory 4-aminophenol derivatives
AU578428B2
(en )
1988-10-27
Trace-labeled conjugates of metallothionein and target- seeking biologically active molecules
ID28003A
(id )
2001-05-03
Turunan-turunan adamantana
YU51095A
(sh )
1998-07-10
Benzokazolil - i benzotiazolil-oksazo lidinoni
FI950169L
(fi )
1995-01-13
PTH:n ja PTHRP:n analogit, niiden synteesi ja käyttö osteoporoosin hoitoon
NZ335146A
(en )
1999-11-29
N-(N'-substituted glycyl)-2-cyanopyrrolidine derivatives and medicaments
AP9801169A0
(en )
1999-08-05
N-hydroxy-B-sulfonyl propionamide derivatives.
UA41879C2
(uk )
2001-10-15
Засіб для лікування мотонейронових захворювань
AU6414994A
(en )
1994-10-11
Composition and method for reducing toxicity of biologically-active factors
NZ337246A
(en )
2000-07-28
Pharmaceutical composition comprising amoxycillin and clavulanate
BG102250A
(en )
1999-02-26
The use of marigold-extracted glycosides for the treatment of psoriasis
EP1294375A4
(en )
2004-06-09
METHOD FOR THE TREATMENT OF SEBORRHOIC DERMATITIS
KR900007424A
(ko )
1990-06-01
세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
PT78628A
(en )
1984-06-01
Pharmaceutical composition with reduced toxicity
NZ510153A
(en )
2002-12-20
Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
ZA963784B
(en )
1997-11-13
Terpenoidic derivatives useful as antitumor agents.
PT1058544E
(pt )
2005-04-29
Inibicao da actividade do tnf
TW238246B
(en )
1995-01-11
Pharmaceutical composition for reducing the renal toxicity and enhancing the effect of antitumor
MY108692A
(en )
1996-10-31
Topical composition
GB2306885B
(en )
1999-07-14
Supersaturated Pharmaceutical Compositions
IL109108A0
(en )
1994-06-24
Salts of (s)-alpha- phenyl - 2 - pyridineethanamine, their preparation and pharmaceutical compositions containing them
HU900525D0
(en )
1991-08-28
Process for the production of medical preparations for treating endotoxinemy
ZA947401B
(en )
1995-05-15
Use of partially methylated beta-cyclodextrins as absorption promoters in the preparation of pharmaceutical compositions for the transcutaneous administration of active principles
TW333453B
(en )
1998-06-11
Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases
ES2165382T3
(es )
2002-03-16
Agentes antiateroescleroticos.